XBOC vs. BOUT

Last updated Jun 4, 2026

XBOC (Innovator U.S. Equity Accelerated 9 Buffer ETF - October) and BOUT (Innovator IBD Breakout Opportunities ETF) are both exchange-traded funds - XBOC is a Defined Outcome fund actively managed by Innovator, while BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index. XBOC is actively managed, while BOUT is passively managed. Over the past 3 years, XBOC returned 11.67%/yr vs 17.42%/yr for BOUT. A 0.67 correlation means they provide meaningful diversification when combined. XBOC charges 0.79%/yr vs 0.80%/yr for BOUT.

Performance

XBOC vs. BOUT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) and Innovator IBD Breakout Opportunities ETF (BOUT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XBOC achieves a 5.40% return, which is significantly lower than BOUT's 31.39% return.

XBOC

• 1D: -0.10%
• 1M: 1.89%
• YTD: 5.40%
• 6M: 6.20%
• 1Y: 13.69%
• 3Y*: 11.67%
• 5Y*: —
• 10Y*: —

BOUT

• 1D: -0.01%
• 1M: 5.85%
• YTD: 31.39%
• 6M: 30.30%
• 1Y: 35.27%
• 3Y*: 17.42%
• 5Y*: 8.25%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XBOC vs. BOUT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
XBOC Innovator U.S. Equity Accelerated 9 Buffer ETF - October	5.40%	11.15%	8.36%	20.06%	-7.58%	3.76%
BOUT Innovator IBD Breakout Opportunities ETF	31.39%	-6.77%	18.82%	13.27%	-22.60%	11.82%

Correlation

The correlation between XBOC and BOUT is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.68
Correlation (3Y) Calculated over the trailing 3-year period	0.63
Correlation (All Time) Calculated using the full available price history since Oct 4, 2021	0.67

The correlation between XBOC and BOUT has been stable across timeframes, ranging from 0.63 to 0.68 - a consistent structural relationship.

XBOC vs. BOUT - Sectors Allocation Comparison

Sectors	XBOC	BOUT
Technology	36.2%	28.4%
Financial Services	11.9%	22.9%
Communication Services	10.9%	2.0%
Consumer Cyclical	10.1%	8.5%
Healthcare	8.4%	2.6%
Industrials	8.1%	9.7%
Consumer Defensive	4.9%	9.7%
Energy	3.5%	3.1%
Utilities	2.3%	7.0%
Real Estate	1.9%	3.5%
Basic Materials	1.8%	9.9%

Return for Risk

XBOC vs. BOUT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBOC

XBOC Risk / Return Rank: 69
XBOC Sharpe Ratio Rank: 66
XBOC Sortino Ratio Rank: 69
XBOC Omega Ratio Rank: 78
XBOC Calmar Ratio Rank: 56
XBOC Martin Ratio Rank: 78

BOUT

BOUT Risk / Return Rank: 51
BOUT Sharpe Ratio Rank: 49
BOUT Sortino Ratio Rank: 47
BOUT Omega Ratio Rank: 46
BOUT Calmar Ratio Rank: 61
BOUT Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBOC vs. BOUT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XBOC	BOUT	Difference
Sharpe ratio: Return per unit of total volatility	2.15	1.71	+0.44
Sortino ratio: Return per unit of downside risk	3.12	2.33	+0.78
Omega ratio: Gain probability vs. loss probability	1.46	1.30	+0.16
Calmar ratio: Return relative to maximum drawdown	2.75	3.01	-0.26
Martin ratio: Return relative to average drawdown	14.85	9.00	+5.85
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XBOC vs. BOUT - Sharpe Ratio Comparison

The current XBOC Sharpe Ratio is 2.15, which is comparable to the BOUT Sharpe Ratio of 1.71. The chart below compares the historical Sharpe Ratios of XBOC and BOUT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XBOC	BOUT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.15	1.71	+0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.43	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.86	0.41	+0.45

Drawdowns

XBOC vs. BOUT - Drawdown Comparison

The maximum XBOC drawdown since its inception was -13.35%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for XBOC and BOUT.

Drawdown Indicators

	XBOC	BOUT	Difference
Max Drawdown Largest peak-to-trough decline	-13.35%	-36.75%	+23.40%
Max Drawdown (1Y) Largest decline over 1 year	-4.99%	-11.76%	+6.77%
Max Drawdown (3Y) Largest decline over 3 years	-12.53%	-25.31%	+12.78%
Max Drawdown (5Y) Largest decline over 5 years	—	-28.28%	—
Current Drawdown Current decline from peak	-0.11%	-0.01%	-0.10%
Average Drawdown Average peak-to-trough decline	-2.08%	-12.29%	+10.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.92%	3.93%	-3.01%

Volatility

XBOC vs. BOUT - Volatility Comparison

The current volatility for Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) is 0.78%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 5.96%. This indicates that XBOC experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XBOC	BOUT	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.78%	5.96%	-5.18%
Volatility (6M) Calculated over the trailing 6-month period	5.19%	16.05%	-10.86%
Volatility (1Y) Calculated over the trailing 1-year period	6.41%	20.79%	-14.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	9.90%	19.48%	-9.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	9.90%	22.93%	-13.03%

XBOC vs. BOUT - Expense Ratio Comparison

XBOC has a 0.79% expense ratio, which is lower than BOUT's 0.80% expense ratio.

Dividends

XBOC vs. BOUT - Dividend Comparison

XBOC has not paid dividends to shareholders, while BOUT's dividend yield for the trailing twelve months is around 0.26%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
BOUT Innovator IBD Breakout Opportunities ETF	0.26%	0.34%	0.60%	1.32%	1.35%	0.00%	0.00%	0.00%	0.22%
XBOC Innovator U.S. Equity Accelerated 9 Buffer ETF - October	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both XBOC and BOUT in my portfolio?

XBOC and BOUT have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XBOC or BOUT?

BOUT has higher volatility (5.96%) compared to XBOC (0.78%). In terms of maximum drawdown, XBOC dropped -13.35% vs BOUT's -36.75%.

Which ETF is better, XBOC or BOUT?

On 3-year performance, BOUT leads with 17.42% vs 11.67% for XBOC. On fees, XBOC is cheaper at 0.79% per year. On volatility, XBOC has been the lower-risk option at 0.78%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, XBOC or BOUT?

Over the 3-year period, BOUT has performed better with a 17.42% return vs 11.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, XBOC or BOUT?

XBOC is cheaper with a 0.79% expense ratio, compared with 0.80% for BOUT.

Which ETF pays a higher dividend yield, XBOC or BOUT?

BOUT has the higher dividend yield at 0.26%, compared with 0.00% for XBOC.

What is the main difference between XBOC and BOUT?

XBOC is categorized as Defined Outcome, while BOUT is Mid Cap Growth Equities. Their fees differ too: 0.79% for XBOC and 0.80% for BOUT.

Which has better risk-adjusted returns?

XBOC currently has the higher Sharpe Ratio (2.15 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.